Publications of Soni S. Pullamsetti
All genres
Journal Article (82)
41.
Journal Article
11 (1), 1185 (2020)
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension. NATURE COMMUNICATIONS 42.
Journal Article
9 (8), 1755 (2020)
Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas. CELLS 43.
Journal Article
80 (20), pp. 4414 - 4425 (2020)
Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma. CANCER RESEARCH 44.
Journal Article
Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction. BRITISH JOURNAL OF PHARMACOLOGY (2019)
45.
Journal Article
10, 2130 (2019)
A RASSF1A-HIF1 alpha loop drives Warburg effect in cancer and pulmonary hypertension. NATURE COMMUNICATIONS 46.
Journal Article
597 (4), pp. 1103 - 1119 (2019)
Mechanisms contributing to persistently activated cell phenotypes in pulmonary hypertension. JOURNAL OF PHYSIOLOGY-LONDON 47.
Journal Article
53 (1), 1801887 (2019)
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. EUROPEAN RESPIRATORY JOURNAL 48.
Journal Article
10, 2229 (2019)
Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis. NATURE COMMUNICATIONS 49.
Journal Article
9 (4), 2045894019889775 (2019)
Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure. PULMONARY CIRCULATION 50.
Journal Article
10, 2204 (2019)
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension. NATURE COMMUNICATIONS 51.
Journal Article
10 (2), pp. 276 - 293 (2018)
FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis. EMBO MOLECULAR MEDICINE 52.
Journal Article
24 (12), pp. 3339 - 3352 (2018)
Genomic Location of PRMT6-Dependent H3R2 Methylation Is Linked to the Transcriptional Outcome of Associated Genes. CELL REPORTS 53.
Journal Article
197 (2018)
Adipose-Tissue Secretome Induces Bronchial Smooth Muscle Cell Proliferation Via an IL-6/FoxO1 Dependent Mechanism in Offspring of Obese Mice. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 54.
Journal Article
116, pp. 57 - 68 (2018)
Long noncoding RNA LISPR1 is required for S1P signaling and endothelial cell function. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 55.
Journal Article
13 (11), e0207915 (2018)
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis. PLOS ONE 56.
Journal Article
197 (2018)
Comparison of the Antifibrotic Efficacy of the Pan-Histone Deacetylase-Inhibitor Panobinostat Versus the IPF-Drug Pirfenidone in Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 57.
Journal Article
272, pp. 4 - 10 (2018)
Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018. INTERNATIONAL JOURNAL OF CARDIOLOGY 58.
Journal Article
128 (5), pp. 1720 - 1723 (2018)
Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension. JOURNAL OF CLINICAL INVESTIGATION 59.
Journal Article
197 (2018)
Reprogramming of Tumor Associated Macrophages by Modulating Wnt beta-Catenin Signalling in Lung Cancer. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 60.
Journal Article
9 (2), 2045894018805406 (2018)
Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension. PULMONARY CIRCULATION